INDV
Indivior Pharmaceuticals, Inc.
36.00$
+0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 11.4% | 10.7% | 14.0% | 17.8% | 15.0% | 16.1% | 16.8% | 15.9% | 19.4% | 19.9% | |
| 88.6% | 89.3% | 86.0% | 82.2% | 85.0% | 83.9% | 83.2% | 84.1% | 80.6% | 80.1% | |
| 11.2% | 8.1% | 6.7% | 6.8% | 6.2% | 6.6% | 8.2% | 10.6% | 9.0% | 7.8% | |
| – | – | – | 25.0% | 69.1% | 30.2% | 27.9% | 30.5% | 30.6% | 25.7% | |
| 53.7% | 52.4% | 52.9% | 59.5% | 109.1% | 57.0% | 92.2% | 98.4% | 77.9% | 58.8% | |
| 34.9% | 36.9% | 33.0% | 22.7% | -24.1% | 26.9% | -9.0% | -14.3% | 2.7% | 21.4% | |
| 5.3% | 4.3% | 3.2% | 2.8% | 3.7% | 3.3% | 3.2% | 3.2% | 3.5% | 3.6% | |
| 9.3% | 12.5% | 27.7% | 22.9% | -26.7% | 24.0% | -9.9% | -13.6% | 1.2% | 19.3% | |
| 6.0% | 7.2% | 0.3% | 5.9% | -3.9% | -1.9% | -4.9% | -1.8% | 0.9% | 2.3% | |
| 3.3% | 5.3% | 27.4% | 17.1% | -22.9% | 25.9% | -4.9% | -11.8% | 0.2% | 16.9% | |
| 15.4% | 38.1% | 32.3% | 29.3% | -19.0% | 30.1% | -5.1% | -9.1% | 7.1% | 24.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.